{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:57:01Z","timestamp":1790542621315,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015538","name":"Quillen College of Medicine, East Tennessee State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.dadr.2026.100478","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:09:50Z","timestamp":1789052990000},"page":"100478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Examining the effects of pill counts on treatment retention in buprenorphine maintenance therapy"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0264-3055","authenticated-orcid":false,"given":"Jack","family":"Larsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonya","family":"Milam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Troxler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2026.100478_bib1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.drugalcdep.2016.02.045","article-title":"Feasibility and success of cell-phone assisted remote observation of medication adherence (CAROMA) in clinical trials","volume":"163","author":"DeWorsop","year":"2016","journal-title":"Drug. Alcohol. Depend."},{"issue":"25","key":"10.1016\/j.dadr.2026.100478_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates - United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"5","key":"10.1016\/j.dadr.2026.100478_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/ADM.0000000000000057","article-title":"Factors affecting noncompliance with buprenorphine maintenance treatment","volume":"8","author":"Fareed","year":"2014","journal-title":"J. Addict. Med."},{"issue":"12","key":"10.1016\/j.dadr.2026.100478_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11916-022-01091-1","article-title":"Pill counting as an intervention to enhance compliance and reduce adverse outcomes with analgesics prescribed for chronic pain conditions: a systematic review","volume":"26","author":"Gill","year":"2022","journal-title":"Curr. Pain. Headache Rep."},{"issue":"2","key":"10.1016\/j.dadr.2026.100478_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/ADM.0000000000001087","article-title":"Harm reduction approach to increasing self-reported safe medication storage among pregnant and parenting people receiving opioid use disorder treatment","volume":"17","author":"Grist","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2026.100478_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1669269","article-title":"Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.dadr.2026.100478_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2018.01.015","article-title":"Perceptions and practices addressing diversion among US buprenorphine prescribers","volume":"186","author":"Lin","year":"2018","journal-title":"Drug. Alcohol. Depend."},{"issue":"5","key":"10.1016\/j.dadr.2026.100478_bib8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J. Addict. Med."},{"issue":"2s","key":"10.1016\/j.dadr.2026.100478_bib9","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.36076\/ppj.2017.s92","article-title":"Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines","volume":"20","author":"Manchikanti","year":"2017","journal-title":"Pain. Physician"},{"key":"10.1016\/j.dadr.2026.100478_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jsat.2015.05.002","article-title":"Concordance of Direct and Indirect Measures of Medication Adherence in A Treatment Trial for Cannabis Dependence","volume":"57","author":"McRae-Clark","year":"2015","journal-title":"J. Subst. Abus. Treat."},{"issue":"7","key":"10.1016\/j.dadr.2026.100478_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4088\/JCP.v60n0706","article-title":"Measurement of compliance with naltrexone in the treatment of alcohol dependence: research and clinical implications","volume":"60","author":"Namkoong","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.dadr.2026.100478_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.dadr.2026.100478_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2018.04.035","article-title":"Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes","volume":"190","author":"Peng","year":"2018","journal-title":"Drug. Alcohol. Depend."},{"key":"10.1016\/j.dadr.2026.100478_bib14","unstructured":"Substance Abuse and Mental Health Service Administration (2018). Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, and Families. Treatment Improvement Protocol (TIP) Series, No. 63. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK574910\/"},{"key":"10.1016\/j.dadr.2026.100478_bib15","doi-asserted-by":"crossref","unstructured":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. (2020). J Addict Med, 14(2S Suppl 1), 1-91. https:\/\/doi.org\/10.1097\/adm.0000000000000633","DOI":"10.1097\/ADM.0000000000000633"},{"issue":"6","key":"10.1016\/j.dadr.2026.100478_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.18500","article-title":"Ongoing Gaps in Buprenorphine Treatment-Urgency and Opportunity","volume":"8","author":"Wakeman","year":"2025","journal-title":"JAMA Netw. Open."},{"issue":"3","key":"10.1016\/j.dadr.2026.100478_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5055\/jom.2016.0334","article-title":"Acceptability of the use of cellular telephone and computer pictures\/video for \"pill counts\" in buprenorphine maintenance treatment","volume":"12","author":"Welsh","year":"2016","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.dadr.2026.100478_bib18","series-title":"Balanced national controlled medicines policies to ensure medical access and safety","author":"World Health Organization","year":"2024"},{"issue":"3","key":"10.1016\/j.dadr.2026.100478_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1521-0391.2012.00335.x","article-title":"Steps physicians report taking to reduce diversion of buprenorphine","volume":"22","author":"Yang","year":"2013","journal-title":"Am. J. Addict."},{"issue":"1","key":"10.1016\/j.dadr.2026.100478_bib20","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1186\/s12889-025-24541-y","article-title":"Global burden, socioeconomic disparities, and spatiotemporal dynamics of opioid use disorder mortality and disability: a comprehensive analysis from the global burden of disease study 2017-2021","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Public. Health"},{"issue":"5","key":"10.1016\/j.dadr.2026.100478_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1046\/j.1360-0443.2003.00354.x","article-title":"Does retention matter? Treatment duration and improvement in drug use","volume":"98","author":"Zhang","year":"2003","journal-title":"Addiction"}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:07:00Z","timestamp":1790539620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724626000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"alternative-id":["S2772724626000715"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100478","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the effects of pill counts on treatment retention in buprenorphine maintenance therapy","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100478"}}